Commissions proposal is the start of the discussion for a balanced package. It is an opportunity to enhance Europe's attractiveness for research, development, and production of medicines. APIFARMA would like to contribute to this public consultation based on some of its specific points of view.
API
APIFARMA
Industry association · Portugal · EU Transparency Register 469601218799-36not in register snapshot
This register number is the organization’s own declaration on its submission. It is not in the 2 Sept 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.
2
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track APIFARMA in PolicySpeak: request access →
Work at APIFARMA? so we know who speaks for it.
Their record over time
APIFARMA filed 2 positions between 26 Apr 2021 and 8 Nov 2023, across 1 of the 583 legislative files tracked here.
2021 · 1 filed2023 · 1 filed
What they argued
For APIFARMA, equity should be the baseline in the future healthcare policy. Europe has the opportunity to foster investment in research and innovation paving the way for a new generation of highly innovative treatments and of highest added value. Only by developing treatments for the unmet needs, reducing delays, and ensuring equal access to therapies can we truly leave no citizen suffering a disease behind.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put APIFARMA next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from APIFARMA’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.